TRACE4AD™ is our AI-powered, CE-cleared medical device that provides early-stage, subject-level risk (low risk or high risk) of being affected by or progressing to dementia within 24 months.
Working through data mining and machine-learning classifiers, TRACE4AD™ performs an automatic reading of the subject's brain MRI study, and it automatically identifies features of brain atrophy that begin to occur following neuronal death caused by AD along with mild cognitive impairment typical of the early stages of AD dementia.
TRACE4BUS™ is our AI-based, CE-cleared medical device that uses machine learning to deeply analyze ultrasound images of BC suspicious breast masses of subjects at risks to provide the breast mass BI-RADS category.
TRACE4BUS™ is based on ultrasound image analytics in the breast region, data mining and machine learning classifiers to support physicians in the reporting of ultrasound-detected suspicious breast masses.
TRACE4OC™ is our AI-based, CE-cleared medical device that provides the woman's level of risk of being affected by ovarian cancer.
Our solution leverages the power of machine learning to deeply analyze US images of adnexal ovarian masses of women at risks, with the aim of providing the individual level of risk (very low risk or medium-high risk) of being affected by ovarian cancer.
Trace4DigitalTwin™ is our proprietary platform that aggregates patient health information and contextualizes it against population data to support strategic and clinical planning.
Trace4Research™ is our proprietary platform based on Artificial Intelligence and Data/Image Analytics.
Through Trace4Research™, highly specialized AI algorithmsare offered as support to non-specialized users in a user-friendly and robust way, following a very simple workflow and usability.
Trace4Telemed™ is our state-of-the-art platform that enables on-line remote interaction between patients and physicians, delivering instant visit, examination, consultation, advise, treatment and monitoring from anywhere.
